30 likes | 344 Views
Stroke or systemic embolic events in large NOAC trials, vs warfarin. Ruff et al ., The Lancet, 2013. S ecundary efficacy and safety outcomes in large NOAC trials, vs. warfarin. Ruff et al ., The Lancet, 2013. Major bleeding events in large NOAC trials, vs warfarin.
E N D
Stroke or systemic embolic events in large NOAC trials, vs warfarin Ruff et al., The Lancet, 2013
Secundary efficacy and safety outcomes in large NOAC trials, vs. warfarin Ruff et al., The Lancet, 2013
Major bleeding events in large NOAC trials, vs warfarin Ruff et al., The Lancet, 2013